MPM Asset Management Investors BV2014 LLC — SEC insider filings
SEC reporting owner CIK 1609495. 45 insider filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 45 filings on record, filed 2020-10-08 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 399,535 shares, $6,618,784 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 141 legs across 41 filings — 5,214,514 shares, $65,250,738 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 706,825 shares @ $20.00 ($14,136,500) in Harpoon Therapeutics, Inc., filed 2021-01-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. (ITOS) | — | 19 | — | 73 legs · 1,535,388 sh · $34,207,377 | 3 |
| Harpoon Therapeutics, Inc. (HARP) | — | 7 | — | 25 legs · 1,201,935 sh · $24,300,362 | 1 |
| Entrada Therapeutics, Inc. (TRDA) | 10% owner | 6 | 1 leg · 100,000 sh · $2,000,000 | 14 legs · 540,669 sh · $4,517,581 | 4 |
| Werewolf Therapeutics, Inc. (HOWL) | — | 11 | 1 leg · 125,759 sh · $2,012,144 | 29 legs · 1,936,522 sh · $2,225,419 | 7 |
| Oncorus, Inc. (ONCR) | 10% owner | 1 | 1 leg · 173,776 sh · $2,606,640 | — | 4 |
| TCR2 THERAPEUTICS INC. (TCRR) | 10% owner | 1 | — | — | 1 |
Insider filings — MPM Asset Management Investors BV2014 LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 38,500 @ $7.11 · Sale (S): 192,500 @ $7.41 · Sale (S): 28,837 @ $7.13 | EDGAR |
| 2026-09-03 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 29,088 @ $7.06 · Sale (S): 25,131 @ $7.19 · Sale (S): 32,263 @ $7.17 | EDGAR |
| 2026-08-31 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 38,922 @ $7.20 · Sale (S): 3,733 @ $7.01 · Sale (S): 44,259 @ $6.99 | EDGAR |
| 2026-08-26 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 21,623 @ $7.34 · Sale (S): 26,522 @ $7.54 · Sale (S): 14,569 @ $7.06 | EDGAR |
| 2025-12-04 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 59,277 @ $0.89 · Sale (S): 57,225 @ $0.87 · Sale (S): 83,230 @ $0.97 | EDGAR |
| 2025-12-01 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 60,733 @ $0.98 · Sale (S): 20,277 @ $0.99 · Sale (S): 60,917 @ $0.94 | EDGAR |
| 2025-11-25 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 64,331 @ $0.83 · Sale (S): 88,802 @ $0.98 · Sale (S): 42,533 @ $0.92 | EDGAR |
| 2025-11-20 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 52,627 @ $0.93 · Sale (S): 66,324 @ $0.94 · Sale (S): 41,152 @ $0.89 | EDGAR |
| 2025-11-17 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 90,951 @ $0.98 · Sale (S): 61,640 @ $0.93 · Sale (S): 57,061 @ $0.95 | EDGAR |
| 2025-11-12 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 68,480 @ $1.11 · Sale (S): 48,570 @ $1.18 · Sale (S): 55,810 @ $1.14 · Sale (S): 40,669 @ $1.09 | EDGAR |
| 2025-11-06 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 140,488 @ $1.22 · Sale (S): 47,950 @ $1.22 · Sale (S): 54,452 @ $1.21 | EDGAR |
| 2025-11-03 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 86,936 @ $1.43 · Sale (S): 114,044 @ $1.28 · Sale (S): 94,063 @ $1.29 | EDGAR |
| 2025-10-29 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC | Sale (S): 72,709 @ $1.72 · Sale (S): 69,068 @ $1.64 · Sale (S): 134,240 @ $1.55 | EDGAR |
| 2025-05-15 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, EVNIN LUKE, Foley Todd | Sale (S): 630,191 @ $8.06 | EDGAR |
| 2025-04-30 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd | Option exercise/expiry (X): 22,758 @ $0.09 · Sale (S): 1,963 @ $1.05 · Option exercise/expiry (X): 4,015 (derivative) @ $0 · Option exercise/expiry (X): 18,743 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 22,935 @ $20.77 · Sale (S): 21,787 @ $20.23 | EDGAR |
| 2023-06-05 | 4 | TCR2 THERAPEUTICS INC. (TCRR) jointly with MPM BioVentures 2014, L.P., Foley Todd, EVNIN LUKE, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM ASSET MANAGEMENT LLC | Other (J): 4,158,964 @ $0 | EDGAR |
| 2022-01-06 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 94,745 @ $42.05 · Sale (S): 19,366 @ $43.20 · Sale (S): 6,768 @ $45.32 · Sale (S): 7,671 @ $46.47 · Sale (S): 18,135 @ $42.03 | EDGAR |
| 2021-12-07 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 17,569 @ $34.68 · Sale (S): 2,419 @ $35.44 · Sale (S): 179 @ $36.26 · Sale (S): 8,469 @ $32.35 · Sale (S): 1,171 @ $33.57 · Sale (S): 508 @ $34.08 · +3 more | EDGAR |
| 2021-12-02 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 5,861 @ $34.62 · Sale (S): 28,076 @ $35.19 · Sale (S): 6,042 @ $33.82 · Sale (S): 5,457 @ $34.61 · Sale (S): 896 @ $35.34 · Sale (S): 29,757 @ $33.74 · +1 more | EDGAR |
| 2021-11-30 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 6,545 @ $35.49 · Sale (S): 6,129 @ $36.03 · Sale (S): 10,073 @ $34.46 · Sale (S): 298 @ $35.37 | EDGAR |
| 2021-11-24 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Other (J): 15,671 @ $0 · Sale (S): 9,307 @ $37.16 · Sale (S): 11,807 @ $37.81 · Sale (S): 19,645 @ $36.21 · Sale (S): 359 @ $36.50 · Sale (S): 4,868 @ $35.20 · +2 more | EDGAR |
| 2021-11-04 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Conversion (C): 3,816,760 · Conversion (C): 509,024 · Purchase (P): 100,000 @ $20 · Conversion (C): 27,617,675 (derivative) @ $0 · Conversion (C): 3,683,241 (derivative) @ $0 | EDGAR |
| 2021-10-18 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 8,893 @ $27.53 · Sale (S): 2,039 @ $28.01 · Sale (S): 6,167 @ $27.14 | EDGAR |
| 2021-10-14 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 8,521 @ $27.09 · Sale (S): 20,929 @ $27.13 · Sale (S): 27,320 @ $27.30 | EDGAR |
| 2021-10-12 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 1,149 @ $27 · Sale (S): 2,032 @ $27.01 · Sale (S): 48,812 @ $27.24 | EDGAR |
| 2021-10-05 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 6,855 @ $27 · Sale (S): 20,711 @ $27.06 | EDGAR |
| 2021-09-30 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 19,214 @ $27 · Sale (S): 2,292 @ $27 | EDGAR |
| 2021-09-27 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 36,213 @ $27.96 · Sale (S): 717 @ $28.38 · Sale (S): 4,913 @ $27.81 · Sale (S): 11,625 @ $27.09 | EDGAR |
| 2021-09-23 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 19,635 @ $27.47 · Sale (S): 14,294 @ $27.54 | EDGAR |
| 2021-09-20 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 21,253 @ $28.47 · Sale (S): 45,698 @ $28.82 · Sale (S): 10,602 @ $27.03 · Sale (S): 13,701 @ $27.84 | EDGAR |
| 2021-09-16 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 17,938 @ $27.50 · Sale (S): 3,623 @ $27.99 · Sale (S): 23,113 @ $27.79 · Sale (S): 991 @ $28.15 | EDGAR |
| 2021-09-13 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 22,725 @ $28.97 · Sale (S): 6,760 @ $27.86 · Sale (S): 6,771 @ $28.73 · Sale (S): 21,384 @ $27.64 | EDGAR |
| 2021-09-08 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 30,474 @ $29.18 · Other (J): 31,340 @ $0 · Sale (S): 11,152 @ $28.61 · Sale (S): 940 @ $29.10 | EDGAR |
| 2021-05-06 | 4 | Werewolf Therapeutics, Inc. (HOWL) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd | Conversion (C): 2,298,430 · Conversion (C): 763,809 · Purchase (P): 125,759 @ $16 · Conversion (C): 19,925,321 (derivative) @ $0 · Conversion (C): 6,621,546 (derivative) @ $0 | EDGAR |
| 2021-04-15 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd, EVNIN LUKE | Sale (S): 1,657 @ $19.35 · Sale (S): 286 @ $20.08 · Sale (S): 121 @ $20.06 · Sale (S): 1,550 @ $20.83 · Sale (S): 1,052 @ $20.49 | EDGAR |
| 2021-04-13 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd, EVNIN LUKE | Sale (S): 10,300 @ $23.67 · Sale (S): 1,637 @ $20.72 · Sale (S): 811 @ $21.52 · Sale (S): 48 @ $22.68 | EDGAR |
| 2021-04-13 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 119 @ $29.99 | EDGAR |
| 2021-04-09 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., EVNIN LUKE, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 3,164 @ $32.07 · Sale (S): 1,842 @ $32.84 · Sale (S): 777 @ $33.84 · Other (J): 15,670 @ $0 · Sale (S): 19,057 @ $30.51 · Sale (S): 247 @ $31.01 | EDGAR |
| 2021-02-12 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd, GADICKE ANSBERT, EVNIN LUKE | Sale (S): 183,051 @ $20 | EDGAR |
| 2021-02-09 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd, GADICKE ANSBERT, EVNIN LUKE | Sale (S): 10,172 @ $20.01 · Sale (S): 72,128 @ $20.04 · Sale (S): 9,400 @ $20.25 | EDGAR |
| 2021-02-04 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd, GADICKE ANSBERT, EVNIN LUKE | Sale (S): 48,421 @ $20.13 · Sale (S): 41,922 @ $20.21 · Sale (S): 29,730 @ $20.37 | EDGAR |
| 2021-01-27 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd, GADICKE ANSBERT, EVNIN LUKE | Sale (S): 13,006 @ $21.23 · Sale (S): 1,363 @ $21.08 · Sale (S): 706,825 @ $20 | EDGAR |
| 2021-01-22 | 4 | Harpoon Therapeutics, Inc. (HARP) jointly with MPM BioVentures 2014, L.P., MPM ASSET MANAGEMENT LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Foley Todd, GADICKE ANSBERT, EVNIN LUKE | Sale (S): 15,694 @ $23.95 · Sale (S): 2,000 @ $24.71 · Other (J): 101,646 · Sale (S): 20,979 @ $22.11 · Sale (S): 4,887 @ $22.61 · Sale (S): 200 @ $23.77 · +1 more | EDGAR |
| 2020-10-08 | 4 | Oncorus, Inc. (ONCR) jointly with MPM BioVentures 2014, L.P., Foley Todd, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM ASSET MANAGEMENT LLC | Conversion (C): 1,783,879 · Conversion (C): 775,975 · Purchase (P): 173,776 @ $15 · Conversion (C): 1,783,879 (derivative) @ $0 · Conversion (C): 775,975 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1609495 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs